Or. Admin. R. 333-116-0715 - Training for the Parenteral Administration of Unsealed Byproduct Material Requiring a Written Directive
Except as provided in OAR 333-116-0740, the
(1) Is an authorized user under OAR
333-116-0680 for uses listed in 333-116-0680(2)(b)(F)(iii) or
333-116-0680(2)(b)(F)(iv) or equivalent U.S. Nuclear Regulatory Commission or
Agreement State requirements; or
(2) Is an authorized user under OAR
333-116-0690 or 333-116-0720, or equivalent U.S. Nuclear Regulatory Commission
or Agreement State requirements and who meets the requirements in section (4)
of this rule; or
(3) Is certified
by a medical specialty board whose certification process has been recognized by
the U.S. Nuclear Regulatory Commission or an Agreement State under OAR
333-116-0690 or 333-116-0720, and who meets the requirements in section (4) of
this rule.
(4) Has successfully
completed 80 hours of classroom and laboratory training, applicable to
parenteral administrations listed in OAR 333-116-0680(2)(b)(F)(ii).
(a) The training must include:
(A) Radiation physics and
instrumentation;
(B) Radiation
protection;
(C) Mathematics
pertaining to the use and measurement of radioactivity ;
(D) Chemistry of byproduct material for
medical use; and
(E) Radiation
biology; and
(b) Has work
experience, under the supervision of an authorized user who meets the
requirements in OAR 333-116-0680, 333-116-0715, 333-116-0740 or equivalent U.S.
Nuclear Regulatory Commission or Agreement State requirements, in the
parenteral administrations listed in OAR 333-116-0680(2)(b)(F)(iii). A
supervising authorized user who meets the requirements in OAR 333-116-0680,
333-116-0715 or U.S. Nuclear Regulatory Commission or Agreement State
requirements, must have experience in administering dosages in the same
category or categories as the individual requesting authorized user status. The
work experience must involve:
(A) Ordering,
receiving, and unpacking radioactive materials safely, and performing the
related radiation surveys;
(B)
Performing quality control procedures on instruments used to determine the
activity of dosages, and performing checks for proper operation of survey
meters;
(C) Calculating, measuring,
and safely preparing patient or human research subject dosages;
(D) Using administrative controls to prevent
a medical event involving the use of unsealed byproduct material ;
(E) Using procedures to contain spilled
byproduct material safely, and using proper decontamination procedures;
and
(F) Administering dosages to
patients or human research subjects, that include at least three cases
involving the parenteral administration as specified in OAR
333-116-0680(2)(b)(F)(iii); and
(c) Has obtained written attestation that the
individual has satisfactorily completed the requirements in section (4) of this
rule, and is able to independently fulfill the radiation safety related duties
as an authorized user for the parenteral administration of unsealed byproduct
material requiring a written directive. The written attestation must be
obtained from either:
(A) A preceptor
authorized user who meets the requirements in OAR 333-116-0680, 333-116-0715,
333-116-0740, or equivalent U.S. Nuclear Regulatory Commission or Agreement
State requirements. A preceptor authorized user who meets the requirements in
OAR 333-116-0680, 333-116-0715 or equivalent U.S. Nuclear Regulatory Commission
or Agreement State requirements, must have experience in administering dosages
in the same category or categories as the individual requesting authorized user
status; or
(B) A residency program
director who affirms in writing that the attestation represents the consensus
of the residency program faculty where at least one faculty member is an
authorized user who meets the requirements in OAR 333-116-0680, 333-116-0715,
333-116-0740 or equivalent U.S. Nuclear Regulatory or Agreement State
requirements, has experience in administering dosages in the same dosage
category or categories as the individual requesting authorized user status, and
concurs with the attestation provided by the residency program director . The
residency training program must be approved by the Residency Review Committee
of the Accreditation Council for Graduate Medical Education or the Royal
College of Physicians and Surgeons of Canada or the Council on Postdoctoral
Training of the American Osteopathic Association and must include training and
experience specified in section (4) and subsection (4)(b) of this
rule.
Notes
Statutory/Other
Statutes/Other Implemented: ORS 453.605 - 453.807
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.